In-situ hybridization-based quantification of hTR: A possible biomarker in malignant melanoma

Histopathology

Volumn 66, Issue 5, 2015, Pages 747-751

  Vagner, Josephine ^a   Steiniche, Torben ^a   Stougaard, Magnus ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Biomarker; hTERC; hTERT; hTR; in situ hybridization; Melanoma; Rolling circle amplification; Telomerase

Indexed keywords

FORMALDEHYDE; PARAFFIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; RNA; TELOMERASE RNA; TUMOR MARKER;

ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MELANOMA; NEVUS; PRIORITY JOURNAL; TISSUE MICROARRAY; ENZYMOLOGY; METABOLISM; PROCEDURES; SKIN NEOPLASMS;

BIOMARKERS, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MELANOMA; NEVUS; RNA; SKIN NEOPLASMS; TELOMERASE;

EID: 84924546158     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12501     Document Type: Article

References (10)

1. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266; 2011-2015.
2. Pirker C, Holzmann K, Spiegl-Kreinecker S et al. Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes. Melanoma Res. 2003; 13; 483-492.
3. Horn S, Figl A, Rachakonda PS et al. TERT promoter mutations in familial and sporadic melanoma. Science 2013; 339; 959-961.
4. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science 2013; 339; 957-959.
5. Heidenreich B, Nagore E, Rachakonda PS et al. Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma. Nat. Commun. 2014; 5; 3401.
6. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 1996; 56; 645-650.
7. Tomlinson RL, Abreu EB, Ziegler T et al. Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells. Mol. Biol. Cell 2008; 19; 3793-3800.
8. Stougaard M, Lohmann JS, Zajac M, Hamilton-Dutoit S, Koch J. In situ detection of non-polyadenylated RNA molecules using Turtle Probes and target primed rolling circle PRINS. BMC Biotechnol. 2007; 7; 69.
9. Ramirez RD, D'Atri S, Pagani E et al. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia 1999; 1; 42-49.
10. Ruden M, Puri N. Novel anticancer therapeutics targeting telomerase. Cancer Treat. Rev. 2013; 39; 444-456.